Baker Brothers Advisors - CELSUS THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

CELSUS THERAPEUTICS PLC's ticker is CLTX and the CUSIP is 15119A202. A total of 14 filers reported holding CELSUS THERAPEUTICS PLC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of CELSUS THERAPEUTICS PLC
ValueSharesWeighting
Q4 2014$3,235,000
-21.3%
673,8870.0%0.03%
-36.5%
Q3 2014$4,111,000
+10.9%
673,8870.0%0.05%
+15.6%
Q2 2014$3,706,000
-15.3%
673,8870.0%0.04%
-19.6%
Q1 2014$4,374,000–673,887–0.06%–
 Download
Other shareholders
CELSUS THERAPEUTICS PLC shareholders Q2 2014
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 286,508$166,0000.02%
MORGAN STANLEY 8$00.00%
UBS Group AG 3,350$2,0000.00%
Citadel Advisors 15,249$9,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 600$348,0000.00%
View complete list of CELSUS THERAPEUTICS PLC shareholders